Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
暂无分享,去创建一个
N. Powe | T. Meyer | T. Hostetter | J. Coresh | T. Shafi | M. Melamed | Seungyoung Hwang | T. Sirich | Natalie S. Plummer | T. Banerjee | J. Coresh | Tanushree Banerjee
[1] N. Powe,et al. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. , 2017, Journal of the American Society of Nephrology : JASN.
[2] D. Kuypers,et al. Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. , 2016, Journal of the American Society of Nephrology : JASN.
[3] Connie M. Rhee,et al. Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients. , 2016, Journal of the American Society of Nephrology : JASN.
[4] N. Powe,et al. Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study. , 2016, Journal of the American Society of Nephrology : JASN.
[5] Jun Wang,et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota , 2015, Nature.
[6] Alan B Leichtman,et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] N. Powe,et al. Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators , 2015, PloS one.
[8] S. Poitevin,et al. The cardiovascular effect of the uremic solute indole-3 acetic acid. , 2015, Journal of the American Society of Nephrology : JASN.
[9] Max Nieuwdorp,et al. Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes , 2014, Diabetes Care.
[10] T. Meyer,et al. Approaches to uremia. , 2014, Journal of the American Society of Nephrology : JASN.
[11] R. Vanholder,et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. , 2014, Journal of the American Society of Nephrology : JASN.
[12] T. Meyer,et al. Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion. , 2014, Journal of the American Society of Nephrology : JASN.
[13] Jens Roat Kultima,et al. Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.
[14] N. Powe,et al. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators , 2013, BMC Nephrology.
[15] Mai-Szu Wu,et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] G. Beck,et al. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. , 2012, American Society of Nephrology. Clinical Journal.
[17] Bertram L Kasiske,et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). , 2011, Kidney international.
[18] Chih-jen Wu,et al. Serum Concentration of p-Cresol and Indoxyl Sulfate in Elderly Hemodialysis Patients , 2011 .
[19] N. Powe,et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] K. Verbeke,et al. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[21] K. Verbeke,et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. , 2008, Kidney international.
[22] T. Stijnen,et al. Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.
[23] Francesco Locatelli,et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2003, The New England journal of medicine.
[24] M. Rocco,et al. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] A. Verstraete,et al. Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact. , 2001, Clinical chemistry.
[26] N W Levin,et al. Design and statistical issues of the hemodialysis (HEMO) study. , 2000, Controlled clinical trials.
[27] J. Dwyer,et al. The hemodialysis pilot study: nutrition program and participant characteristics at baseline. The HEMO Study Group. , 1998, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.